Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Lung Neoplasms

To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group four times for 1-2 hours each.

Qualitative Group Interviews

The team will meet with the stakeholder advisory group four times for 1-2 hours each

Stakeholder advisory group

Gina Kruse, MD, MPH

Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.

Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.

Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers

A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to Sponsor Investigator or designee. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Acceptability of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Intervention appropriateness measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

National Cancer Institute (NCI)

University of Colorado, Denver

To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each

Qualitative Group Interviews: One time interview, 60-90 minutes

Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each

Stakeholder Advisory Group

To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each.

Qualitative Group Interviews: One time interview, 60-90 minutes

Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each

Age, Categorical

Sex: Female, Male

Race and Ethnicity were not collected from any participant.

Race and Ethnicity Not Collected

United States

Region of Enrollment

Dr. Gina Kruse, PI

Feasibility of Intervention Measure

Acceptability of Intervention Measure

Intervention Appropriateness Measure

To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group four times for 1-2 hours each.

Qualitative Group Interviews: One time interview, 60-90 minutes

Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each

Spots Global Cancer Trial Database for qualitative group interviews